BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025 16:01 ET Ā | Source: BridgeBio Pharma, Inc. PALO ALTO,…
NextGen Digital Platforms Inc. Responds to OTC Markets Request on Recent Promotional Activity
October 02, 2025 21:00 ET Ā | Source: NextGen Digital Platforms Inc. Vancouver,…
CORRECTION Algae-C Acquisition by Rockcliffe Labs
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Algae-C Inc. (āAlgae-Cā) today issues…
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE…
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2025 17:20 ET Ā | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Oct.…
Nexteer Showcases Motion-by-Wire Innovations & Shares Insights on Software-Defined Vehicles at MOVE America
Steer-by-Wire, Rear-Wheel Steering, Brake-by-Wire, Software & More in Detroit September 24-25 DETROIT,…
Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
Carlsbad, CA, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq:…
ROCKET DOCTOR AI INC. ANNOUNCES AUTOMATIC CONVERSION OF SPECIAL WARRANTS
Vancouver, British Columbia, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI…
Intermap Technologies Files Prospectus Supplement
The prospectus supplement, the corresponding base shelf prospectus and any amendment to…
Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin
PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company…